Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Viterbo – page 2

17 clinical trials in Viterbo, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Viterbo at a glance
17
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

17 trials in Viterbo

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Consorzio Oncotech
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Eli Lilly & Co.

Breast cancer

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Decitabine
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus

IgA nephropathy

Not recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sibeprenlimab
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Viterbo

What the registry says about research in the country

01 Oncology Studies

Innovative research focusing on breast cancer treatments, including studies comparing chemotherapy timing with aromatase inhibitors and evaluating new targeted therapies. Additional trials explore treatments for metastatic colorectal cancer and renal cell carcinoma.

  • Breast Cancer Treatment Optimization
  • Colorectal Cancer Therapies
  • Targeted Cancer Treatments

Multiple studies are investigating combination therapies and treatment sequencing to improve patient outcomes.

02 Hematologic Disorders

Critical research in Acute Myeloid Leukemia and myelodysplastic syndromes, exploring innovative combination treatments and transplantation approaches for patients with specific genetic markers.

  • Leukemia Treatment Strategies
  • Stem Cell Transplantation
  • Targeted Therapies

Studies focus on personalized treatment approaches based on genetic markers and disease characteristics.

03 Nephrology Research

Groundbreaking studies in kidney disease treatments, including research on IgA Nephropathy and innovative therapies for patients with chronic kidney disease and high proteinuria.

  • Chronic Kidney Disease Management
  • Novel Drug Combinations
  • Targeted Therapeutic Approaches

Research aims to improve treatment outcomes and slow disease progression in various kidney conditions.

04 Mental Health Studies

Research examining new approaches for Major Depressive Disorder, focusing on adjunctive treatments and combination therapies to enhance antidepressant effectiveness.

  • Depression Treatment Enhancement
  • Combination Therapy Evaluation
  • Treatment Resistance Solutions

Studies aim to improve outcomes for patients with inadequate response to standard treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.